Acute treatment of atrial fibrillation: why and when to maintain sinus rhythm

Area of Science:

• Cardiology
• Electrophysiology
• Public Health

Background:

• Atrial fibrillation (AFib) presents significant long-term health risks, including thromboembolic events, reduced exercise capacity, and heart failure exacerbation.
• While anticoagulation manages thromboembolic risks, AFib negatively impacts quality of life and imposes healthcare burdens.
• Current management strategies include rate control and thromboembolic prophylaxis for permanent AFib, or rhythm control aiming to restore and maintain sinus rhythm.

Purpose of the Study:

• To evaluate the efficacy and long-term benefits of restoring and maintaining sinus rhythm in patients with atrial fibrillation.
• To compare the outcomes of rhythm control versus rate control strategies for atrial fibrillation management.
• To assess the impact of AFib on exercise capacity, quality of life, and healthcare costs.

Main Methods:

• Review of existing literature on atrial fibrillation management strategies.
• Analysis of data from ongoing management trials in AFib.
• Case-by-case evaluation of feasibility and realism for restoring sinus rhythm.

Main Results:

• Cardioversion restores sinus rhythm in over 80% of patients, but recurrence is common.
• Antiarrhythmic drugs can reduce AFib recurrence rates, enhancing the efficacy of rhythm control.
• Short-to-medium term improvements in patient well-being are evident with rhythm control, but long-term data are limited.

Conclusions:

• Restoring and maintaining sinus rhythm is a treatment goal for AFib, often enhanced by antiarrhythmic drugs.
• The long-term economic viability and efficacy of rhythm control strategies require further investigation.
• Decisions regarding rhythm control should be individualized based on patient-specific factors and feasibility.